Novavax Inc (NVAX)

1.46
NASDAQ : Health Care
Prev Close 1.43
Day Low/High 1.41 / 1.54
52 Wk Low/High 1.16 / 8.95
Avg Volume 20.17M
Exchange NASDAQ
Shares Outstanding 271.25M
Market Cap 387.88M
EPS -0.60
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

UPDATE -- Novavax To Host Conference Call To Discuss Third Quarter Financial Results On November 9, 2016

UPDATE -- Novavax To Host Conference Call To Discuss Third Quarter Financial Results On November 9, 2016

Financial results conference call will include Investor and Analyst webcast presentation

Novavax To Host Conference Call To Discuss Third Quarter Financial Results On November 9, 2016

Novavax To Host Conference Call To Discuss Third Quarter Financial Results On November 9, 2016

Financial results conference call will include Investor and Analyst webcast presentation

5 Stocks Under $10 That Could Make You a Lot of Money

5 Stocks Under $10 That Could Make You a Lot of Money

These stocks trading for less than $10 a share are within range of triggering big breakout trades. Here's how to trade them from here.

These 7 Stocks Are Trading on Big Volume -- Here's What to Do With Them Now

These 7 Stocks Are Trading on Big Volume -- Here's What to Do With Them Now

Here's a technical look at how to trade some of the most active stocks on the market right now.

5 Big-Volume Stocks to Add to Your Buy List -- Plus 2 to Avoid

5 Big-Volume Stocks to Add to Your Buy List -- Plus 2 to Avoid

Here's a technical look at how to trade some of the most active stocks on the market right now.

Twitter, Intel, Starbucks: Doug Kass' Views

Twitter, Intel, Starbucks: Doug Kass' Views

Doug Kass shares his thoughts on what goes on his best ideas list and what's still moving down.

Underlying Risks in Speculative Biotechs; Trump Speaks, Bonds Slide : Best of Kass

Underlying Risks in Speculative Biotechs; Trump Speaks, Bonds Slide : Best of Kass

In highlights from this week's trading diary and posts, Kass tells us about underlying risks in speculative biotechs and how Donald Trump's voice makes bonds slide.

Novavax's Chart Looked Good, Until It Didn't

Novavax's Chart Looked Good, Until It Didn't

Things were looking up and then today happened.

Look to Costamare for Value in Shipping

Look to Costamare for Value in Shipping

It's safe to say these guys know what they are doing.

Novavax's Steep Decline Underlines Small-Cap Biotech Risk

But we remain committed to our position in TherapeuticsMD.

Novavax (NVAX) Stock Tumbles on Vaccine Trial Failure, Ratings Downgrades

Novavax (NVAX) Stock Tumbles on Vaccine Trial Failure, Ratings Downgrades

Novavax (NVAX) stock rating was reduced at several firms this morning after the company's RSV-F vaccine didn't achieve its primary and secondary endpoints in a clinical trial.

Analysts' Actions -- Citigroup, Comerica, Novavax, PepsiCo and More

Analysts' Actions -- Citigroup, Comerica, Novavax, PepsiCo and More

Here are Friday's top research calls, including downgrades for Citigroup and Novavax, an upgrade Comerica and new coverage of PepsiCo.

Novavax (NVAX) Stock Tanking in After-Hours Trading on Vaccine Trial Failure

Novavax (NVAX) Stock Tanking in After-Hours Trading on Vaccine Trial Failure

Novavax (NVAX) announced late Thursday that its RSV-F vaccine for lower respiratory tract disease did not meet its objectives in a clinical trial.

Bought Aerie Earlier? Congratulations

Bought Aerie Earlier? Congratulations

An update on some recent small biotech recommendations.

4 Biotechs Set to Provide a Shot in the Arm

4 Biotechs Set to Provide a Shot in the Arm

Each company has approaching catalysts.

4 Biotechs Set to Provide a Shot in the Arm

4 Biotechs Set to Provide a Shot in the Arm

Each company has approaching catalysts.

'Mad Money' Lightning Round: Lockheed Martin Can Fly to $210

'Mad Money' Lightning Round: Lockheed Martin Can Fly to $210

Cramer says McCormick is up too much and he's not chasing Clayton Williams Energy.

Jim Cramer's 'Mad Money' Recap: The Urge to Merge Rules Wall Street

Jim Cramer's 'Mad Money' Recap: The Urge to Merge Rules Wall Street

There are too many companies in just about every sector of this market, Cramer says.

3 Biotech-Investing Mistakes to Avoid

3 Biotech-Investing Mistakes to Avoid

These are the biggest errors that I've made over the years.

Novavax (NVAX) Stock Dropping as Q2 Results Miss Expectations

Novavax (NVAX) Stock Dropping as Q2 Results Miss Expectations

Novavax (NVAX) reported a larger-than-anticipated loss and weak revenue for the 2016 second quarter.

How Will Novavax (NVAX) Stock React After Q2 Miss?

How Will Novavax (NVAX) Stock React After Q2 Miss?

Novavax (NVAX) revenue declined 82% year-over-year for the second quarter.